Disc Medicine Inc
(IRON)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,357 | -76,429 | -46,827 | -35,969 | -40,837 |
| Depreciation Amortization | -5,148 | 100 | 89 | 32 | 322 |
| Accounts payable and accrued liabilities | -4,681 | -3,741 | 526 | 1,315 | -2,408 |
| Other Working Capital | 3,231 | -2,953 | 2,125 | 1,286 | 337 |
| Other Operating Activity | 22,029 | 9,561 | 1,835 | 5,802 | 9,878 |
| Operating Cash Flow | $-93,926 | $-73,462 | $-42,252 | $-27,534 | $-32,708 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -505 | -89 | -151 | -68 | -22 |
| Purchase Of Investment | -386,627 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 94,800 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-292,332 | $-89 | $-151 | $-68 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,988 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | 14,000 |
| Common Stock Issued | 190,719 | 239,379 | 151,122 | 68 | 163 |
| Other Financing Activity | -1,393 | 0 | -2,144 | 89,861 | 20,084 |
| Financing Cash Flow | $218,314 | $239,379 | $148,978 | $89,929 | $34,247 |
| Beginning Cash Position | 360,616 | 194,788 | 88,213 | 25,886 | 3,309 |
| End Cash Position | 192,672 | 360,616 | 194,788 | 88,213 | 4,826 |
| Net Cash Flow | $-167,944 | $165,828 | $106,575 | $62,327 | $1,517 |
| Free Cash Flow | |||||
| Operating Cash Flow | -93,926 | -73,462 | -42,252 | -27,534 | -32,708 |
| Capital Expenditure | -505 | -89 | -151 | -68 | -22 |
| Free Cash Flow | -94,431 | -73,551 | -42,403 | -27,602 | -32,730 |